» Authors » Abdulrahman J Sabbagh

Abdulrahman J Sabbagh

Explore the profile of Abdulrahman J Sabbagh including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 44
Citations 304
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Alkhotani A, Baeesa S, Alshanqiti M, Alsinani T, Najjar A, Alkhayyat S, et al.
World J Oncol . 2025 Jan; 16(1):95-103. PMID: 39850529
Background: The significance of histological grading and peritumoral edema (PTE) in predicting intracranial meningioma recurrence among Saudis is often neglected. This study aimed to evaluate the impact of these factors...
2.
Albalkhi I, Shafqat A, Bin-Alamer O, Mallela A, Gersey Z, Fernandes Cabral D, et al.
Childs Nerv Syst . 2024 Apr; 40(7):2033-2042. PMID: 38649470
Pediatric optic pathway/hypothalamic gliomas (OPHG) pose challenges in treatment due to their location and proximity to vital structures. Surgical resection plays a key role in the management of OPHG especially...
3.
Albalawi S, Hafiz B, Turki A, Alturkustani M, Bakhsh S, Sabbagh A
Cureus . 2024 Feb; 16(1):e52341. PMID: 38361697
Infantile hemangioma is a common benign vascular tumor in children, but it is very unusual to be found intracranially. Our literature review identified 44 reported cases. Presentation can vary from...
4.
Althomali M, Aljohani O, Sabbagh A
Childs Nerv Syst . 2023 Oct; 40(2):581-586. PMID: 37897525
Background: Chiari malformation type III (CM III), a rare hindbrain anomaly, often presents with various concurrent anomalies. This paper reports a unique case of CM III associated with Klippel-Feil syndrome...
5.
Alomar S, Moshref R, Moshref L, Sabbagh A
Neurosurg Rev . 2023 Oct; 46(1):261. PMID: 37779130
Epilepsy is a common condition that affects approximately 1% of the world's population, with about one-third being refractory epilepsy. Temporal lobe epilepsy is the most common type of drug-resistant epilepsy,...
6.
Butt N, Kurdi M, Fadul M, Hakamy S, Addas B, Faizo E, et al.
Pathol Res Pract . 2023 Sep; 250:154816. PMID: 37725880
Background: MHC-I expression is a crucial factor in cancer immunity, and its regulations can impact tumor progression and recurrence. The mechanism through which glioblastoma use MHC-I to avoid immunosurveillance has...
7.
Kurdi M, Fadul M, Alkhayyat S, Sabbagh A, Alsinani T, Alkhotani A, et al.
Pathol Res Pract . 2023 Aug; 248:154733. PMID: 37536020
Background: NDRG2 is a tumour suppressor gene involved in tumor growth inhibition. Its effect on tumour recurrence remains controversial. The aim of this study is to explore the dual effect...
8.
Kurdi M, Fadul M, Addas B, Faizo E, Alkhayyat S, Bamaga A, et al.
J Neurooncol . 2023 Jul; 163(3):693-705. PMID: 37402091
Background: Corticosteroid is commonly used before surgery to control cerebral oedema in brain tumours and is frequently continued throughout treatment. Its long-term effect of on the recurrence of WHO-Grade 4...
9.
Bokhari R, Elkaim L, Shlobin N, Alotaibi N, Sabbagh A, Weil A, et al.
J Neurosurg Pediatr . 2023 Jun; 32(3):343-350. PMID: 37327188
Objective: Delayed cerebral ischemia (DCI) associated with vasospasm is well described in the setting of aneurysmal subarachnoid hemorrhage (SAH). In addition, DCI is very infrequently encountered in patients who have...
10.
Algethami R, Moshref R, Sabbagh A
Asian J Neurosurg . 2022 Dec; 17(4):683-686. PMID: 36570742
Idiopathic intracranial hypertension includes ventriculoperitoneal shunt (VPS) insertion, with a reported complication of shunt revision in 25% of the cases 1 year after insertion. We report a case of a...